Thus, the identification of a disequilibrium linkage between ANRIL SNPs and altered energy metabolism might be envisioned as a vital discovery and a promising target of therapy in the field of obesity and diabetes treatments. Here, CDKN2B-AS1 is linked to obesity disorder.